Stewart Deborah 4

What Happened Deborah Stewart, Senior Vice President and Chief Accounting Officer of Aveanna Healthcare (AVAH), disposed of a total of 29,815 shares in open-market sales between Feb 17–19, 2026 for aggregate proceeds of about $220,197. The individual reported transactions were: 7,738 shares at $7.65 (Feb 17) = $59,158; 10,896 shares at $7.38 (Feb 18) = $80,444; and 11,181 shares at $7.21 (Feb 19) = $80,595. These were sales (not purchases) and appear to be routine dispositions rather than new purchases.

Key Details

• Transaction dates & reported prices:
  • 2026-02-17: 7,738 shares @ $7.65 (proceeds $59,158) — footnote indicates weighted-price range $7.47–$7.97.
  • 2026-02-18: 10,896 shares @ $7.38 (proceeds $80,444) — footnote indicates weighted-price range $7.175–$7.53.
  • 2026-02-19: 11,181 shares @ $7.21 (proceeds $80,595) — footnote indicates weighted-price range $7.06–$7.29.
• Total shares sold: 29,815; total reported proceeds: ~$220,197.
• Shares owned after transaction: Not specified in the information provided in this summary.
• Notable footnotes:
  • F1: Sales include shares automatically sold to satisfy tax withholding obligations on vested equity awards.
  • F2–F4: Each line reflects weighted average sale prices from aggregate transactions handled by the company’s stock plan administrator; the filer can provide a breakdown of shares sold at each price upon request.
• Filing: Report filed Feb 19, 2026 covering transactions from Feb 17–19, 2026 (no late-filing flag noted in the provided data).

Context These sales were tied to tax-withholding on vested awards (per the filing), a common administrative reason executives sell shares that does not necessarily signal a change in their view of the company. For retail investors, purchases are generally more informative about insider sentiment than routine withholding sales; here the activity appears administrative rather than a discretionary open-market sell program.